Combination contraceptives: effects on weight
- 25 January 2006
- reference entry
- Published by Wiley
- No. 1,p. CD003987
- https://doi.org/10.1002/14651858.cd003987.pub2
Abstract
Weight gain is often considered a side effect of combination hormonal contraceptives, and many women and clinicians believe that an association exists. Concern about weight gain can limit the use of this highly effective method of contraception by deterring the initiation of its use and causing early discontinuation among users. However, a causal relationship between combination contraceptives and weight gain has not been established. The aim of the review was to evaluate the potential association between combination contraceptive use and changes in weight. We searched the computerized databases MEDLINE, POPLINE, CENTRAL, EMBASE, and LILACS for studies of combination contraceptives. We also wrote to known investigators and manufacturers to request information about other published or unpublished trials not discovered in our search. All English-language, randomized controlled trials were eligible if they had at least three treatment cycles and compared a combination contraceptive to a placebo or to a combination contraceptive that differed in drug, dosage, regimen, and/or study length. All titles and abstracts located in the literature searches were assessed. Data were entered and analyzed with RevMan, and a second author verified the data entered. Depending on the data available, the weighted mean difference using a fixed effects model with 95% confidence intervals (CI) was calculated for the mean change in weight between baseline and post-treatment measurements or the Peto odds ratio with 95% confidence intervals was calculated using the proportion of women who gained or lost more than a specified amount of weight. The three placebo-controlled, randomized trials did not find evidence supporting a causal association between combination oral contraceptives or a combination skin patch and weight gain. Most comparisons of different combination contraceptives showed no substantial difference in weight. In addition, discontinuation of combination contraceptives because of weight gain did not differ between groups where this was studied. Available evidence was insufficient to determine the effect of combination contraceptives on weight, but no large effect was evident.Keywords
This publication has 67 references indexed in Scilit:
- Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrelContraception, 2001
- Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trialsContraception, 2001
- Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyContraception, 1999
- A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptivesContraception, 1998
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and toleranceContraception, 1997
- Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, on lipid metabolism in an open randomized trialContraception, 1996
- Changes in androgens during treatment with four low-dose contractptivesContraception, 1996
- A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and toleranceContraception, 1995
- Long-interval treatment regimen with a desogestrel-containing oral contraceptiveContraception, 1993
- A study comparing a gestoden triphasic formulation with a fixed combination OCAdvances in Contraception, 1989